AbbVie Inc. — Director's Dealing 2018

Dec 13, 2018

SEC Form 4/A — Form 4/A

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2018-12-10

Reporting Person: Stewart Jeffrey Ryan (SVP, US Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-10	Common stock, $0.01 par value	A	11595	—	Acquired	41073	Direct

Footnotes

F1: These securities represent restricted stock units granted under the AbbVie 2013 Incentive Stock Program. They vest in annual increments of 3,865 shares on each of 12/10/2019, 12/10/2020 and 12/10/2021, and include the right to have stock withheld for tax purposes.